AmpliPhi Biosciences
Trending Articles
Related Content
Finance
AmpliPhi Biosciences establishes Scientific Advisory Board and appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based therapies to treat drug-resistant bacterial infections, announces the formation of its Scientific Advisory Board (SAB) and the appointment of Timothy K. Lu, M.D., Ph.D., as Chairman of the SAB